Search

Search Constraints

You searched for: Author/Creator ,

Search Results

5561. Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40. Issue 4 (9th January 2018)

5562. Alzheimer's disease brain atrophy subtypes are associated with incident dementia in subjective cognitive complaint and mild cognitive impairment: Neuroimaging / Optimal neuroimaging measures for early detection. (7th December 2020)

5563. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Issue 8 (14th June 2016)

5568. Alzheimer's disease genetic risk variants show brain cell type‐specific associations with protein levels in cerebrospinal fluid. (1st February 2022)

5569. Alzheimer's disease genetic risk variants show brain cell type‐specific associations with protein levels in cerebrospinal fluid. (December 2021)

5570. Alzheimer's disease GWAS weighted by multi‐omics and endophenotypes identifies novel risk loci: Genetics/genetic factors of Alzheimer's disease. (7th December 2020)